All In Biotech

Free tool

FAERS Monitor: Exxua

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021164 or its brand name (Exxua, Gepirone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4

Serious

1

25% of reports

Hospitalization

0

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • panic attack2
  • anger1
  • anxiety1
  • blood pressure increased1
  • drug ineffective1
  • headache1
  • illness1
  • insomnia1
  • migraine1
  • muscle twitching1
  • nervousness1
  • overdose1
  • product communication issue1
  • rash papular1
  • suicidal ideation1

Reports by year received

View as table
YearReports
20264

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,155 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product communication issue1596.1109.2148
panic attack2288.6108.3322
rash papular1234.643.058
muscle twitching1228.141.856
anger1155.528.538
nervousness1100.718.424
suicidal ideation157.410.513
migraine155.110.113
illness151.09.312
blood pressure increased134.46.38
overdose124.44.55
insomnia119.73.64
anxiety118.53.44
headache18.41.51
drug ineffective14.00.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.